To assess the frequency of effective contraceptive use among women with bipolar disorder (BD) aged 50 years or younger and identify associated sociodemographic, clinical, and pharmacological characteristics.
Approach:
Study design and data source: Secondary analysis of the MONTRA survey, conducted in France in 2010–2011 among patients with clinician-confirmed DSM-IV BD receiving routine psychiatric care.
Participants: Analyses included female participants aged 18–50 years.
Measures: Effective contraception included oral contraceptives, patches, vaginal rings, implants, intrauterine devices, female sterilisation, condoms, and diaphragms; withdrawal was excluded. Sociodemographic, clinical, and treatment characteristics were assessed.
Interpretation:
The provided context describes the study rationale and methods but does not report results.
Limitations:
The supplied context does not include the sample size or study findings.
Data were collected during routine clinical encounters over a four-day survey period and included clinician assessment and patient self-report.
Conclusion:
The study aimed to characterize effective contraceptive use and its correlates among women with BD of reproductive age.
